Panaxin Pharmaceuticals Private Limited
About Panaxin Pharmaceuticals Private Limited
Data last updated:
Panaxin Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the chemicals sector. It was incorporated on 01 September 2021.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2021PTC154530.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Veerla Saithirumal Rao and Ajay Kumar Beerla.
Its last annual general meeting (AGM) was held on 12 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Flat No.302 Baghwan Residency Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Company details
Contact details
Panaxin Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat No.302 Baghwan Residency Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Panaxin Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Panaxin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Panaxin Pharmaceuticals Private Limited
Panaxin Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veerla Saithirumal Rao | Director | 01 Sep 2021 | 5 Years 2 Months | As last reported |
| Ajay Kumar Beerla Also directs: Open Access Talks Media LLP, Kan Urban Village LLP, Innovative Infylogics Consultants LLP and 2 more | Director | 01 Sep 2021 | 5 Years 2 Months | As last reported |
| Gurram Bharath Chandra | Director | 01 Sep 2021 | 5 Years 2 Months | As last reported |
| Karthik Bolgam Also directs: Lims Hospitals Private Limited | Director | 01 Sep 2021 | 5 Years 2 Months | As last reported |
Legal cases
No court or tribunal cases involving Panaxin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Panaxin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Panaxin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Panaxin Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Ajay Kumar Beerla was appointed as Director on 01 Sep 2021.
Frequently asked questions
Panaxin Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Panaxin Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in manufacturing, within the chemicals industry. It was incorporated on 01 September 2021 and is registered under CIN U24230TG2021PTC154530. The company has been struck off by the Registrar of Companies and is no longer operational.
Panaxin Pharmaceuticals had 4 directors:
- Veerla Saithirumal Rao - Director
- Ajay Kumar Beerla - Director
- Gurram Bharath Chandra - Director
- Karthik Bolgam - Director
The CIN (Corporate Identification Number) of Panaxin Pharmaceuticals is U24230TG2021PTC154530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Panaxin Pharmaceuticals is at Flat No.302 Baghwan Residency Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Panaxin Pharmaceuticals was incorporated on 01 September 2021. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Panaxin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 12 August 2024. Year-wise statements from FY 2022 are in the company report.
Panaxin Pharmaceuticals operated in the chemicals industry, in the manufacturing segment. It worked in this industry before it was struck off.
Ajay Kumar Beerla was appointed as Director on 01 Sep 2021. Gurram Bharath Chandra was appointed as Director on 01 Sep 2021. Karthik Bolgam was appointed as Director on 01 Sep 2021. Panaxin Pharmaceuticals has 4 board changes on record in total.
Panaxin Pharmaceuticals can be reached at its registered office: Flat No.302 Baghwan Residency Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
